There was no correlation between IgE concentrations and staging in the general cancer group (r = 0.25, p = 0.60), prostate cancer (r = 0.12, p = 0.62), HNSCC (r = 0.07, p = 0.78), and stomach cancer (r = 0.22, p = 0.37). This evidence concerns the gene IGHE and head and neck squamous cell carcinoma.